Concepedia

Chi Hoon Park

CH

Statistics

Publications

37

Citations

1.5K

H-Index

20

Active since

2005

Affiliations

Korea Research Institute of Chemical Technology(Current)

Korea University of Science and Technology

Chungnam National University

Seoul National University

Chungbuk National University

Chi Hoon Park is an author at Korea Research Institute of Chemical Technology specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2005–2023

37

Publications

37

Quercetin, a potent inhibitor against β-catenin/Tcf signaling in SW480 colon cancer cells

Chi Hoon Park, Joon Young Chang, Eun Ryeong Hahm et al. · Biochemical and Biophysical Research Communications · 2005 · 334 citations

, , +11

The inhibitory mechanism of curcumin and its derivative against β‐catenin/Tcf signaling

Chi Hoon Park, Eun Ryeong Hahm, Seyeon Park et al. · FEBS Letters · 2005 · 126 citations · Full text

, , +15

Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC)

Chung Hyo Kang, Dong-Ho Lee, Chong Ock Lee et al. · Biochemical and Biophysical Research Communications · 2018 · 120 citations

, , +14

Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer

Minsung Kim, Suhkneung Pyo, Chung Hyo Kang et al. · PLoS ONE · 2018 · 101 citations · Full text

, , +16

A novel cereblon modulator for targeted protein degradation

Sung Ah Kim, Ara Go, Seunghyun Jo et al. · European Journal of Medicinal Chemistry · 2019 · 63 citations

, , +10

1–5 of 37